Skip to main content

NorthCrest Asset Manangement, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1893159 PLYMOUTH, MN

Position in HALO

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$3,533,890
+$1,562,417 QoQ
Shares Held
45,150
+48.0% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#13
of 109 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NorthCrest Asset Manangement, LLC holds $17,717,995 across 23 Biotechnology names. HALO ranks #2 (19.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 HALO
Halozyme Therapeutics, Inc.
This page
45,150 $3,533,890

All Filings in HALO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,533,890 45,150
2026-03-31 $1,971,473 30,504
2025-12-31 $2,114,162 31,414
2025-09-30 $2,240,757 30,553
2025-06-30 $1,137,001 21,857
2025-03-31 $1,906,578 29,879
2024-12-31 $1,427,558 29,859
2024-09-30 $1,708,728 29,852
2024-06-30 $1,563,050 29,852
2024-03-31 $1,214,379 29,852
2023-12-31 $1,361,015 36,824
2023-09-30 $1,406,676 36,824
2023-06-30 $1,328,241 36,824
2023-03-31 $1,406,308 36,824
2022-12-31 $1,345,685 23,650
2022-09-30 $929,190 23,500
2022-06-30 $1,034,000 23,500
2022-03-31 $937,180 23,500
2021-12-31 $422,205 10,500